Thromboembolic events and thromboprophylaxis associated with immunomodulators in multiple myeloma patients: a real-life study.

V LeclercL KarlinC HerledanL MarchalA BaudouinA GouraudA G CaffinV LarbreA LazarethE BachyG SallesH GhesquièresC RioufolFlorence Ranchon

Published in: Journal of cancer research and clinical oncology (2021)

Thromboprophylaxis was systematically performed in myeloma patients treated with immunomodulatory drugs in this real-life retrospective cohort. However, the choice of anticoagulant or anti-platelet agent remains debatable, as adherence to existing guidelines was variable.

Keyphrases

multiple myeloma
venous thromboembolism
newly diagnosed
end stage renal disease
ejection fraction
atrial fibrillation
chronic kidney disease
cross sectional
metabolic syndrome
patient reported outcomes
decision making